Resultados de la búsqueda 1-10 of 15933 for chemoprevention
The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will ...
... chemoprevention studies that will culminate in launching chemoprevention trials at Mayo. Collection of Peripheral Blood Mononuclear Cells from Normal ...
... chemoprevention studies that will culminate in launching chemoprevention trials at Mayo. Circulating Tumor Nucleic Acids to Monitor Treatment Response in ...
Breast cancer chemoprevention Drugs that reduce risk. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo? Para donar. ¿Te gustaría hacer una donación ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Rochester, Minn. This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to find ...
The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast or recurred ...
The purpose of this study is to determine the response rate to PLX-038 in patients with metastatic ovarian, primary peritoneal, and fallopian tube cancers that ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?